Date published: 2026-1-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

1500005A01Rik Activators

1500005A01Rik Activators encompass a range of chemical compounds that influence cellular pathways to indirectly enhance the functional activity of 1500005A01Rik. Forskolin, through its effect on adenylyl cyclase, indirectly facilitates the activation of 1500005A01Rik by raising intracellular cAMP levels, which in turn activate PKA that may phosphorylate 1500005A01Rik, assuming it is a PKA substrate. This cascade of events could enhance the functional activity of 1500005A01Rik by promoting its phosphorylation state. Similarly, Sphingosine-1-phosphate, by engaging S1P receptors, activates the PI3K/Akt pathway, which can lead to the activation of 1500005A01Rik if it is associated with this signaling route. PMA, known for PKC activation, could also enhance the functional activity of 1500005A01Rik through PKC-mediated phosphorylation if it is a part of the PKC signaling network. Epigallocatechin gallate and the PI3K inhibitors LY294002 and Wortmannin may amplify 1500005A01Rik activity by inhibiting kinases that normally suppress its function, thereby relieving an inhibitory effect on 1500005A01Rik.

Further tuning of 1500005A01Rik activity is achieved through the modulation of the MAPK signaling pathway. SB203580 and U0126 act as inhibitors of p38 and MEK1/2, respectively, possibly shifting the signaling equilibrium to favor the activation of 1500005A01Rik if it lies downstream or is regulated in a compensatory manner by these kinases. A23187, by elevating intracellular calcium levels, could potentiate calcium-dependent signaling pathways that activate 1500005A01Rik, assuming it is responsive to calcium-mediated signaling. Additionally, Staurosporine, despite its broad-spectrum kinase inhibition, might selectively enhance the functional activity of 1500005A01Rik by removing inhibitory signals from specific kinases. PD98059, as another MEK inhibitor, could indirectly lead to the functional activation of 1500005A01Rik by initiating alternative signaling pathways. BAPTA-AM, by chelating intracellular calcium, may indirectly lead to the activation of 1500005A01Rik through compensation by calcium signaling pathways. Collectively, these compounds, through their targeted effects on cellular signaling, facilitate the enhancement of 1500005A01Rik's activity by influencing the protein's phosphorylation state, cellular location, or interaction with other proteins within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate (S1P) engages in signaling through S1P receptors, which can activate downstream pathways like PI3K/Akt. If 1500005A01Rik is part of the PI3K/Akt pathway, S1P can enhance its activity through this cascade.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC), which is involved in a multitude of cellular functions. Activation of PKC may lead to the phosphorylation and activation of 1500005A01Rik if it is a substrate or if it is involved in a pathway downstream of PKC.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Epigallocatechin gallate (EGCG) inhibits certain types of kinases and has been shown to affect signaling pathways like MAPK. If 1500005A01Rik activity is suppressed by a particular kinase, EGCG might enhance its function by inhibiting that kinase.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which paradoxically could result in the activation of compensatory pathways that lead to the activation of 1500005A01Rik, if it is involved in such pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor that, by inhibiting PI3K, could lead to the activation of alternative routes that enhance the activity of 1500005A01Rik if it is a part of or regulated by these routes.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is an inhibitor of p38 MAPK, and by inhibiting p38, it may shift cellular signaling in favor of pathways that activate 1500005A01Rik, assuming that 1500005A01Rik is negatively regulated by p38 MAPK.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is an ionophore that increases intracellular calcium levels. If 1500005A01Rik is part of or regulated by calcium-dependent signaling pathways, A23187 may enhance its activity by increasing calcium influx.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a broad-spectrum kinase inhibitor. If 1500005A01Rik is negatively regulated by a kinase that is sensitive to staurosporine, the inhibitor may lift this regulation and enhance the activity of 1500005A01Rik.